Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Experimental Radiation Injuries

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Experimental Radiation Injuries in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Que, M1
Schiene, K1
Witte, OW1
Zilles, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Noninvasive Brain Stimulation Training to Help Recover Brain-related Symptoms[NCT03228472]100 participants (Anticipated)Interventional2017-11-22Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Experimental Radiation Injuries

ArticleYear
Widespread up-regulation of N-methyl-D-aspartate receptors after focal photothrombotic lesion in rat brain.
    Neuroscience letters, 1999, Oct-01, Volume: 273, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoradiography; Brain Ischemia;

1999